400M patients suffer from thyroid dysfunction and thyroid eye disease, a complication of the dysfunction. With a vision of "innovating standard of care to create values for patients and doctors", THYROSCOPE developed the world's first digital monitoring solution for thyroid dysfunction and thyroid eye disease, and is currently working on CE marking and FDA approval focusing on Germany and US with a strong global clinical trial team in each region.